CV Sciences (CVSI) Total Current Liabilities (2010 - 2026)
CV Sciences (CVSI) posted Total Current Liabilities of $5.2 million for Q1 2026, up 3.6% sequentially from $5.0 million in Q4 2025, and down 1.37% YoY from $5.3 million in Q1 2025.
CV Sciences (CVSI) Total Current Liabilities (2010 - 2026) Analysis & Trends
CV Sciences has reported Total Current Liabilities for 17 years, with the latest figure at $5.2 million in Q1 2026.
- Quarterly Total Current Liabilities fell 1.37% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 1.37% YoY) and the FY2025 annual result came in at $5.0 million, down 18.15% from the prior year.
- Total Current Liabilities climbed to $5.2 million in Q1 2026 per CVSI's latest filing, from $5.0 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $14.2 million in Q1 2022 and troughed at $4.8 million in Q3 2025.
- A 5-year average of $7.6 million and a median of $6.1 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities grew 9.94% in 2022, then sank 56.85% in 2023.
- Over 5 years, Total Current Liabilities stood at $13.3 million in 2022, then slumped by 54.07% to $6.1 million in 2023, then fell by 0.1% to $6.1 million in 2024, then decreased by 18.15% to $5.0 million in 2025, then grew by 3.6% to $5.2 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $5.2 million, $5.0 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 4.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.94 Mn |
| Mar 31, 2026 | 5.18 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 5.25 Mn |
| Dec 31, 2024 | 6.11 Mn |
| Sep 30, 2024 | 6.14 Mn |
| Jun 30, 2024 | 6.03 Mn |
| Mar 31, 2024 | 5.96 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 5.85 Mn |
| Mar 31, 2023 | 6.25 Mn |
| Dec 31, 2022 | 13.31 Mn |
| Sep 30, 2022 | 13.54 Mn |
| Jun 30, 2022 | 13.56 Mn |
| Mar 31, 2022 | 14.20 Mn |
| Dec 31, 2021 | 14.46 Mn |
| Sep 30, 2021 | 12.31 Mn |